ArticleCurrent pharmaceutical biotechnology2025

COL1A1, COL1A2, CHN1, and FN1 Promote Tumorogenesis and Act as Markers of Diagnosis and Survival in Gastric Cancer Patients.

Yichao Yan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.